Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

KNSAKNSA

Showing 0 of 7 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in Kiniksa Pharmaceuticals International, plc

As of its Q1 2024 13F, Connor, Clark & Lunn Investment Management held 261,698 shares of KNSA (Kiniksa Pharmaceuticals International), worth $5.2M. Connor, Clark & Lunn Investment Management's 13F filings listed KNSA from Q4 2022 to Q1 2024, 6 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used